Take Action

Home | Faculty & Research Overview | Research

Research Details

Palforzia: Valuing a Treatment for Peanut Allergy

Abstract

On a cold morning in January 2020 in Evanston, Illinois, Clemence Shiffrin, senior vice president for business development at Oakdale Pharmaceuticals, called together her business development team. Shiffrin had a presentation to the company's board of directors scheduled for February 1, just a few weeks away. The board wanted her assessment of the peanut allergy market and of the financial value of an effective therapy. In addition, the board wondered if Oakdale should consider acquiring Aimmune Therapeutics.

Shiffrin's recommendation would play a key role in determining how Oakdale would invest its precious research and development funds and, more immediately, whether the firm would move forward with a major acquisition.

Type

Case

Author(s)

Timothy Calkins, Shaon Ahsan

Date Published

09/09/2021

Discipline

Marketing

Key Concepts

Valuation

Citations

Calkins, Timothy, and Shaon Ahsan. Palforzia: Valuing a Treatment for Peanut Allergy. Case 5-321-501.

KELLOGG INSIGHT

Explore leading research and ideas

Find articles, podcast episodes, and videos that spark ideas in lifelong learners, and inspire those looking to advance in their careers.
learn more

COURSE CATALOG

Review Courses & Schedules

Access information about specific courses and their schedules by viewing the interactive course scheduler tool.
LEARN MORE

DEGREE PROGRAMS

Discover the path to your goals

Whether you choose our Full-Time, Part-Time or Executive MBA program, you’ll enjoy the same unparalleled education, exceptional faculty and distinctive culture.
learn more

Take Action